Charles River provides comprehensive solutions for the biopharmaceutical industry, specialising in Cell and Gene Therapy contract development and manufacturing (CDMO) services. With a robust track record, the company has supported the development of 10 FDA-approved therapies and conducted over 900 studies in this field within the past year. Charles River's end-to-end offering enhances access to scientific and regulatory expertise through its team of multidisciplinary experts, dedicated to assisting clients in overcoming challenges and achieving critical development goals ranging from discovery to commercialisation.

Services include:
- Bioanalytical Services
- Biomarker Research
- Clinical Analysis
- Contract Research (CRO)
- Efficacy Testing
- In Vitro Testing
- Testing
- IND/NDA Submissions
- Microbiological Testing
- Nonclinical Research
- Preclinical Study Design
- Preclinical Testing
- Preclinical Testing Formulations
- Safety
- Toxicology Services & Analysis
- Analytical Services
- Regulatory Services
- Containment
- Protein and Peptide Services
- Cell and Gene Therapy

Charles River remains committed to advancing the pharmaceutical industry through its extensive range of services and expertise. For more information, please visit criver.com.